Archives

by in
Entry Author Date Location
Seattle Genetics Sets Lymphoma Drug Price at $13,500 Per Dose 08/22/11 Seattle
Seattle Genetics: The Next Litmus Test for High Priced Cancer Drugs 08/22/11 National
Seattle Genetics Wins FDA Approval of First Drug, a New Treatment for Lymphomas 08/19/11 Seattle
SeaGen Passes FDA Panel, Ken Stuart’s Journey to Seattle Biomed, the Latest M&A Obsession, & More Seattle-Area Life Sciences News 07/21/11 Seattle
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent 07/18/11 National
Seattle Genetics Lymphoma Drug Gets Second Green Light from FDA Panel 07/14/11 Seattle
Seattle Genetics Wins Unanimous OK for Lymphoma Drug from FDA Panel 07/14/11 Seattle
SeaGen’s Big Day at the FDA, Hutch Nabs $20M HIV Grant, Allozyne’s Nasdaq Plan, & More Seattle-Area Life Sciences News 07/14/11 Seattle
Insider Trader Pleads Guilty in SeaGen Case 07/12/11 Seattle
Seattle Genetics’ New ‘Empowered Antibody’ Looks Clean in FDA Staff Documents 07/12/11 Seattle
Seattle Genetics’ FDA Panel Preview: What You Need to Know This Week 07/12/11 Seattle
SeaGen Preserves Science Culture, Dendreon Sways Medicare, NanoString’s Financing, & More Seattle-Area Life Sciences News 07/07/11 Seattle
Seattle Genetics, On the Verge of Going Commercial, Seeks to Keep Its Scientific Soul 07/05/11 Seattle
Allozyne’s Backdoor IPO, Sound Pharma Fights iPod Deafness, Mirina Vs. Marina Ends, & More Seattle-Area Life Sciences News 06/23/11 Seattle
Cyterix Develops New Twist on an Old Idea, With ‘Smart Bomb’ Cancer Drugs 06/22/11 San Francisco
SeaGen Promotes Dobmeier 06/17/11 Seattle
ASCO Wrap-Up, Pathway Medical Grinds It Out, Gates Foundation’s New Digs, & More in Seattle-Area Life Sciences News 06/09/11 Seattle
ASCO Wrap-Up: The Skinny on Cancer News From All Corners of the U.S. 06/07/11 National
Resolve Maps Out New Biotech Model, SeaGen Expands, Schadt Heads East, & More in Seattle-Area Life Sciences News 05/19/11 Seattle
SeaGen Adds $7.7M Lease 05/13/11 Seattle
Geospiza Sells to PerkinElmer, PATH Vaccine Nabs $100M, Halosource Gets China Approval, & More Seattle-Area Life Sciences News 05/12/11 Seattle
Why Are Drugs Getting Such Weird Brand Names? 05/09/11 National
SeaGen Ends March With $456M Cash 05/05/11 Seattle
Kleiner Perkins’ Bet on a Concrete Stomach, The Gates Foundation’s Out-of-the-Box Ideas, & More Seattle-Area Life Sciences News 05/05/11 Seattle
SeaGen FDA Deadline Set for Aug. 30 05/02/11 Seattle
Life Science Discovery Fund Faces Cuts, Boeing’s Biofuel Push, SeaGen’s Latest Deal, & More Seattle-Area Life Sciences News 04/21/11 Seattle
Genmab Expands SeaGen Alliance 04/19/11 Seattle
SeaGen Strikes Abbott Deal, Omeros Passes Study, Alnylam Fires Back at Tekmira, & More Seattle-Area Life Sciences News 03/24/11 Seattle
SeaGen Inks Abbott Deal 03/22/11 Seattle
Think Obamacare Will Suffocate New Drug Development With Price Controls? Think Again 03/21/11 National
Page 3 of 9 « previous page · next page »